Hopes for a coronavirus treatment were boosted after President Donald Trump announced at a White House press briefing last week that two anti-malaria drugs were a “game-changer” that have shown “very, very encouraging results.”
But scientists and infectious disease experts say Trump’s claims about the drugs — chloroquine and hydroxychloroquine — may be premature.
While some small studies give doctors reason to hope, large clinical trials are needed to determine whether the drugs are truly effective in fighting COVID-19, they say.
